Prime Medicine

PRME • NASDAQ • Stock Fundamentals

Prime Medicine is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Allan Reine, with a market cap of $509.3M.

Market Cap$509.3M

Employees234.0

CEOAllan Reine

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Prime Medicine

Prime Medicine (PRME) has a market capitalization of $509.3M and trades on NASDAQ.

Prime Medicine has approximately 234 employees.